Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Condition(s):Type 1 Diabetes MellitusLast Updated:April 6, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Type 1 Diabetes MellitusLast Updated:April 6, 2021Completed
Condition(s):Mild Cognitive Impairment; Cognitive ImpairmentLast Updated:December 13, 2023Active, not recruiting
Condition(s):Major Depressive Disorder; DepressionLast Updated:January 8, 2024Recruiting
Condition(s):Insulin SensitivityLast Updated:September 5, 2021Completed
Condition(s):Insulin SensitivityLast Updated:December 23, 2013Completed
Condition(s):Hyperglycemia; Stroke, AcuteLast Updated:December 6, 2021Completed
Condition(s):Insulin ResistanceLast Updated:January 26, 2018Completed
Condition(s):Insulin SensitivityLast Updated:May 17, 2023Recruiting
Condition(s):Heart Failure; Diabetes Mellitus, Type 2Last Updated:November 18, 2019Terminated
Condition(s):Out-Of-Hospital Cardiac Arrest; HealthyLast Updated:October 14, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.